Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Inoviq Ltd ( (AU:IIQ) ).
INOVIQ Ltd has announced its Annual General Meeting (AGM) scheduled for November 27, 2025, with a deadline for director nominations set for October 9, 2025. This announcement is part of the company’s ongoing governance and operational activities, potentially impacting its strategic direction and stakeholder engagement.
The most recent analyst rating on (AU:IIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Inoviq Ltd stock, see the AU:IIQ Stock Forecast page.
More about Inoviq Ltd
INOVIQ Ltd is a leader in exosome technology, focusing on next-generation diagnostics and therapeutics to transform cancer care. The company’s product portfolio includes commercial-stage exosome isolation products, clinical-stage diagnostics for ovarian and breast cancers, and a preclinical CAR-exosome therapeutic program for solid tumors.
Average Trading Volume: 107,071
Technical Sentiment Signal: Sell
Current Market Cap: A$45.77M
Learn more about IIQ stock on TipRanks’ Stock Analysis page.